Company intelligence / Profile preview

Guizhou Weikang Zifan Pharmaceutical

Ownership: Private
Development stage: Other

Overview

Guizhou Weikang Zifan Pharmaceutical is a China-based pharmaceutical company specializing in the processing and development of traditional Chinese herbal medicines. The company has contributed to research on Rhizoma Musae decoction, identifying active compounds and their mechanisms in osteoarthritis treatment using advanced analytical techniques. Their products are used both commercially and in ongoing preclinical research.

Therapeutic areas: Rheumatology
Modalities: Small moleculeHerbal medicine (Traditional Chinese Medicine)
Industry: Biotech

Drug pipeline

1 asset

Gukang capsule

Unknown

Partnerships

Academic collaboration with GuiZhou Institute of Subtropical Crops, Guizhou Academy of Agricultural Sciences for ethnopharmacology research on osteoarthritis treatments.

Beyond the preview

Go deeper on Guizhou Weikang Zifan Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Guizhou Weikang Zifan Pharmaceutical.

Explore the full profile